Arkolith/Insider Trading/AYTU/Form 4

Disbrow Joshua R.

Chief Executive OfficerAYTU BIOPHARMA, INC (AYTU) · full profile →Form 4 · filed Jun 10, 2025
Net Buying
Open-Market Buys
$100K
Open-Market Sells
$0
Net Open-Market Flow
$100K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 9, 2025Buy(P)67K$1.50$100K153K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-25-019956) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML